LED Light Therapy in Singapore

It is generally a low-downtime treatment, but suitability still depends on the device, wavelength, dose, medications, photosensitivity and the underlying skin condition. A darker skin tone does not remove the need for proper assessment.

Usually not. It may be an adjunct for selected inflammatory acne, but acne can also involve follicular blockage, hormones, inflammation and scarring risk. The treatment plan should match the acne type and severity.

Photobiomodulation research suggests effects on cellular signalling and repair pathways, but cosmetic change tends to be modest and device-dependent. It should not be presented as equivalent to resurfacing, RF microneedling, ultrasound or surgery.

Claims around coloured LED for pigmentation are less established than many marketing descriptions suggest. Pigmentation should first be diagnosed because melasma, lentigines and post-inflammatory pigmentation behave differently.

Sometimes. Timing depends on the procedure, skin condition and treatment goals. The clinician performing the main procedure should decide whether adjunctive LED is appropriate.

There is no universal course. Protocols vary by device and indication, and a treatment should be continued only when there is a reasonable clinical goal and response.

The proposed mechanism involves light absorption by mitochondrial chromophores, influencing cellular energy production and signalling. It is an active research area rather than settled science, and effects are modest.

No. Photobiomodulation appears to follow a biphasic dose response, where increasing the dose past an optimum reduces rather than improves the effect. Longer and brighter is not automatically better.

They generally deliver lower irradiance than clinical devices and output varies with limited independent verification. For someone who will use one consistently a reputable device may offer modest benefit, but it does not replace treating a diagnosed condition.

Light intensity falls off sharply with distance, so a device held further away delivers substantially less energy. This is why clinical positioning is standardised rather than approximate.

Visible light is recognised as a contributor to pigmentation in darker skin types, which is why melasma patients are advised to use sunscreens with visible-light protection. It deserves specific discussion rather than assumption.

PDT applies a photosensitising agent first, which the light then activates. It is far more powerful with real downtime, and should not be confused with plain LED.

Often, depending on wavelength and device. Bright light close to the eyes can cause discomfort or headache in some people even at non-thermal intensities.

Bring your list. Certain antibiotics, retinoids and other drugs increase photosensitivity, and a non-thermal treatment is not automatically exempt from that consideration.

Non-thermal light is often among the more acceptable options when many active treatments are deferred, though it should still be discussed rather than assumed.

Usually none. Temporary warmth, dryness, mild redness, eye discomfort or headache can occur but typically settle quickly.

No, and any clinic promising that is overselling. LED's value is as a comfortable, low-risk adjunct rather than a transformative treatment.

Cosmetic treatment is generally not claimable. Where light therapy forms part of treatment for a diagnosed condition, check directly with your insurer.

Aquila Medical Center is at 160 Robinson Road, #05-01 SBF Centre Medical Suites, Singapore 068914, in the CBD, a short walk from Tanjong Pagar, Shenton Way and Telok Ayer MRT stations.